B-181 Second-tier newborn screening for X-linked adrenoleukodystrophy: development, validation, and clinical application of an LC-MS/ MS method for the quantification of lysophosphatidylcholines
Kandeepan Karthigesu, Nathan Mclntosh, Matthew Henderson, Murray Potter
Abstract Background Newborn screening (NBS) is a population-based healthcare initiative designed to detect selected disorders that would benefit from early intervention. Newborn Screening Ontario (NSO), Canada, will be adding X-linked adrenoleukodystrophy as an NBS target in 2025. The disorder manifests in several …
ca (code pays fourni par la source)
0 citations
Clinical Chemistry